SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 8-K
Document Type: EX-10.1
Date Filed: 2026-03-25
Accession Number: 0001213900-26-034072
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390026034072/ea028322301ex10-1.htm

Chunk 67 of 68
Word Count: 931
Character Count: 5808

Document Content:

the Common Stock on the day of exercise, or, if on any day such security is not so listed, the average of the highest bid and lowest asked prices on such day in the domestic over-the-counter market as reported by the National Quotation Bureau, Incorporated, or any similar successor organization. If at any time such security is not listed on any securities exchange or the over-the-counter market, the “Market Price” shall be the fair market value thereof as determined in good faith by the Company’s Board of Directors. 8. Certificate of Adjustment. Whenever the Warrant Price or number or type of securities issuable upon exercise of this Warrant is adjusted, as herein provided, the Company shall promptly deliver to the record holder of this Warrant a certificate of an officer of the Company setting forth the nature of such adjustment and a brief statement of the facts requiring such adjustment.

9. Notice
of Proposed Transfers. This Warrant is transferable by the Holder hereof subject to compliance with this Section 9. Prior to any
proposed transfer of this Warrant or the shares of Warrant Stock received on the exercise of this Warrant (the “Securities”),
unless there is in effect a registration statement under the Securities Act of 1933, as amended (the “Securities Act”),
covering the proposed transfer, the Holder thereof shall give written notice to the Company of such Holder’s intention to effect
such transfer. Each such notice shall describe the manner and circumstances of the proposed transfer in sufficient detail, and shall,
if the Company so requests, be accompanied (except in transactions in compliance with Rule 144) by a customary written opinion of legal
counsel who shall be reasonably satisfactory to the Company addressed to the Company and reasonably satisfactory in form and substance
to the Company’s counsel, to the effect that the proposed transfer of the Securities may be effected without registration under
the Securities Act and any applicable state securities laws; provided, however, no such registration statement or opinion
of counsel shall be necessary for a transfer by a Holder to any affiliate of such Holder or any fund managed or advised by the Holder
or its affiliates, or a transfer to any lender, participant or assignee under the Credit Agreement, or a transfer by a Holder which is
a partnership to a partner of such partnership or a retired partner of such partnership who retires after the date hereof, or to the
estate of any such partner or retired partner or the transfer by gift, will or intestate succession of any partner to his spouse or lineal
descendants or ancestors, if the transferee agrees in writing to be subject to the terms hereof to the same extent as if such transferee
were the original Holder hereunder. The Company shall, within a reasonable time and at its expense (other than Holder’s legal fees),
instruct its transfer agent to remove any restrictive legend from any certificate or book-entry statement representing the Securities
to be transferred as above provided if (a) such securities are sold or transferred pursuant to an effective registration statement, (b)
such Shares are eligible for resale under Rule 144 without volume, manner-of-sale, or current public information requirements, or (c)
the Holder provides a customary Rule 144 representation and, if reasonably requested, a legal opinion meeting the standards as provided
above. The Company shall cooperate with the Holder and the transfer agent to facilitate the removal of legends and the settlement of
any permitted transfer as provided above.

10. Replacement
of Warrants. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation
of the Warrant, and in the case of any such loss, theft or destruction of the Warrant, on delivery of an indemnity agreement or security
reasonably satisfactory in form and amount to the Company, and reimbursement to the Company of all reasonable expenses incidental thereto,
and upon surrender and cancellation of the Warrant if mutilated, the Company will execute and deliver, in lieu thereof, a new Warrant
of like tenor.

11. Miscellaneous.
This Warrant shall be governed by the laws of the State of Nevada, without regard to the conflict of laws provisions thereof. The headings
in this Warrant are for purposes of convenience of reference only, and shall not be deemed to constitute a part hereof. The invalidity
or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provisions. All notices
and other communications from the Company to the holder of this Warrant shall be given in writing and shall be deemed effectively given
as provided in the Credit Agreement.

12. Amendment;
Waiver. Any term of this Warrant may be amended, and any provision hereof waived, with the written consent of the Company and the
Holder. Any amendment effected in accordance with this Section shall be binding upon the Holder and the Company.

[THE
NEXT PAGE IS THE SIGNATURE PAGE]

WITNESS WHEREOF, the undersigned officer of the Company has set his hand as of the date first above written.

SYNERGY CHC
CORP.

Name:

Title:

Agreed
and accepted:

ACME
CREDIT PARTNERS FUND I, LP

Acme Credit Investors LLC, its general partner

Acme Credit Partners LLC, its managing member

Name:	Peter Eschmann

Title:	Managing Partner

[Signature
Page to Common Stock Purchase Warrant]

The
undersigned hereby irrevocably covenants to vote all shares of common stock of Synergy CHC Corp. beneficially owned by him (including
any shares subsequently acquired, whether by purchase, option exercise, vesting, conversion, or otherwise) in favor of the “Stockholder
Warrant Approval” referenced in the above Warrant.

Jack
Ross